Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Global efforts to try and treat and eradicate malaria are being hampered by increasing resistance of the disease-causing Plasmodium parasite to anti-malarial drugs.

A new study led by researchers from the Wellcome Trust Centre for Human Genetics has identified genetic markers linked to resistance to the anti-malarial drug piperaquine. This new information can be used as a tool to identify areas where resistance is emerging and where current treatment strategies are likely to fail.

Read more